How to Cycle Peptides
Peptide cycling refers to the practice of using a peptide for a set period (the 'on' phase) followed by a break (the 'off' phase) before resuming. Cycling can help maintain receptor sensitivity, reduce the risk of side effects, and potentially improve long-term results. Not every peptide requires strict cycling, but understanding when and how to cycle is a key part of responsible peptide use.
Last updated: 2026-03-03
What You'll Need
- Written log or spreadsheet for tracking on/off dates
- Calendar reminders for cycle transitions
- Reconstituted peptide vials for the current cycle
- Blood-work requisition (recommended at cycle start and end)
Steps
Identify your peptide class and default cycle length
Different peptide categories have different recommended cycle lengths. GH secretagogues typically run 8-12 weeks on, healing peptides 4-8 weeks, and fat-loss peptides 8-12 weeks. Check the compound-specific section below for your peptide.
Set a clear start date and mark your calendar
Record the exact date you begin. Set calendar reminders for the halfway point (to assess progress) and the planned end date. Consistent tracking prevents accidental overextension of cycles.
Monitor for signs of receptor desensitization
During your on phase, watch for diminishing returns — reduced effects at the same dose, need for higher doses to achieve the same result, or new side effects appearing. These can indicate receptor downregulation and suggest it is time to cycle off.
Transition to the off phase
When your on phase ends, stop the peptide completely. For GH secretagogues, some practitioners taper the dose over 3-5 days rather than stopping abruptly. During the off phase, receptors resensitize and your body returns to baseline signaling.
Use the off phase productively
The off phase is not wasted time. Maintain your training, nutrition, and sleep. Consider running blood work 2-3 weeks into the off phase to check biomarkers like IGF-1, fasting glucose, and liver/kidney panels. This data informs your next cycle.
Evaluate and plan your next cycle
After the off period, review your log. Did the peptide achieve its goal? Were side effects manageable? Adjust your next cycle length or dose based on the data. If results were strong with minimal sides, you can repeat the same protocol. If diminishing returns occurred early, consider a longer off phase or a lower dose.
Why Cycle Peptides?
Peptide cycling serves several purposes supported by pharmacological principles:
- Receptor sensitivity: Continuous stimulation of a receptor can lead to downregulation — the cell reduces the number of available receptors or decreases their sensitivity. Cycling allows receptors to "reset," maintaining the peptide's effectiveness over time[1]
- Hormonal homeostasis: Peptides that influence growth hormone, insulin, or other hormones can shift your body's baseline if used indefinitely. Breaks allow your endocrine system to return to its natural setpoints
- Side-effect management: Some side effects (water retention, numbness/tingling, appetite changes) are cumulative. Regular breaks reduce the chance of chronic issues
- Cost efficiency: Cycling means you use fewer vials over a 12-month period compared to continuous use, which can significantly reduce cost
Not all peptides require cycling with equal urgency. The necessity depends primarily on the peptide's mechanism of action and how it interacts with receptor systems.
Which Peptides Need Cycling?
| Peptide Class | Examples | Cycling Needed? | Typical On/Off |
|---|---|---|---|
| GH Secretagogues | Sermorelin, Ipamorelin, CJC-1295, Hexarelin | Yes — strongly recommended | 8–12 weeks on / 4–6 weeks off |
| Healing / Repair | BPC-157, TB-500, Thymosin Beta-4 | Often goal-dependent | 4–8 weeks on / 2–4 weeks off |
| Fat-Loss Peptides | AOD-9604, Tesofensine | Recommended | 8–12 weeks on / 4 weeks off |
| GLP-1 Agonists | Semaglutide, Tirzepatide, Retatrutide | Typically continuous (Rx) | Ongoing per prescriber guidance |
| Nootropic Peptides | Semax, Selank, Dihexa | Recommended | 4–6 weeks on / 2–4 weeks off |
| Longevity / Mitochondrial | Epitalon, MOTS-c, SS-31 | Protocol-dependent | 10–20 days on / 4–6 months off (Epitalon); 4–8 weeks on / 4 weeks off (MOTS-c) |
GH Secretagogue Cycling Protocols
Growth hormone secretagogues are the peptide class where cycling matters most. These peptides work by stimulating the pituitary gland to release more GH. Continuous, uninterrupted use can lead to pituitary desensitization — the gland produces less GH in response to the same signal over time[2].
Standard GH Secretagogue Cycle
- On phase: 8–12 weeks at a consistent daily dose
- Off phase: 4–6 weeks with no GH secretagogue use
- Dosing frequency: Most secretagogues are dosed once or twice daily, typically before bed and/or upon waking (fasted)
The Ipamorelin + CJC-1295 Cycle
The ipamorelin and CJC-1295 stack is the most popular GH secretagogue combination. A common cycle looks like this:
- Weeks 1–12: Ipamorelin 200–300 mcg + CJC-1295 (no DAC) 100 mcg, injected together subcutaneously before bed
- Weeks 13–16: Off phase — no secretagogues
- Week 17: Resume cycle if desired
For Hexarelin, cycles are often shorter (4–8 weeks) because hexarelin causes more pronounced desensitization than ipamorelin. Read more in our CJC-1295 + ipamorelin stack guide.
Healing Peptide Cycling Protocols
Healing peptides like BPC-157 and TB-500 are often used to address a specific injury or condition. Cycling these peptides is less about receptor desensitization (BPC-157 works through multiple pathways, not a single receptor) and more about assessing whether the therapeutic goal has been met.
Injury-Focused Protocol
- Acute phase: 4–6 weeks at full dose (e.g., BPC-157 250–500 mcg/day)
- Assessment: Evaluate healing progress — pain levels, range of motion, imaging if applicable
- Decision: If healed, discontinue. If improving but not resolved, take 2 weeks off and run another 4-week cycle
The BPC-157 + TB-500 stack is commonly run for 6–8 weeks for moderate-to-severe injuries. Check our dosage guide for compound-specific dosing ranges.
Maintenance / Prevention Protocol
Some users run low-dose BPC-157 (100–250 mcg/day) for gut health or general recovery support. In this context, cycling 4 weeks on / 2 weeks off is a reasonable approach to avoid unnecessary continuous use.
Signs You Should Cycle Off
Even within a planned cycle, these warning signs suggest you should begin your off phase early:
- Diminishing returns: The effects you initially noticed (better sleep, faster recovery, fat loss) have stalled or reversed despite consistent dosing
- Increased side effects: Water retention, joint stiffness, carpal tunnel symptoms, or persistent numbness/tingling in extremities (common with GH elevation)
- Elevated fasting glucose: GH secretagogues can raise blood sugar over time. If fasting glucose rises above 100 mg/dL on blood work, consider cycling off[3]
- Mood or sleep disruption: Some peptides can affect sleep architecture or mood with extended use
- Blood work abnormalities: Elevated IGF-1 beyond the reference range, changes in liver or kidney markers, or other unexpected lab results
When in doubt, err on the side of cycling off. You can always resume after a break.
Tracking Your Cycles Effectively
Keeping a cycle log helps you optimize future protocols. Record the following for each cycle:
- Peptide name, dose, and frequency
- Start and end dates of on/off phases
- Subjective effects — energy, sleep quality, recovery speed, body composition changes (weekly notes)
- Side effects — type, severity, when they appeared
- Blood work — pre-cycle, mid-cycle (optional), and post-cycle panels
A simple spreadsheet works well for tracking. Review your log before starting each new cycle to identify what worked and what to adjust.
Related Tools & Guides
- Peptide dosage chart — reference dosage ranges for every compound
- Peptide reconstitution calculator — calculate concentrations and syringe units
- Dosage calculator — find the right dose by body weight
- Beginner's guide to peptides — start here if you are new to peptides
- Peptide cycle length guide — deep dive into cycle duration research